3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
13
OTHER
7
OTHER_GOV
1
NIH
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
2
Sarcoma
1
Other solid neoplasm
1
NET
1
Gynecologic
1
Gastrointestinal
1
Endocrine
1
Conditions
Thymoma
1
Neuroendocrine Tumors
1
Mesothelioma
1
Interventions
pembrolizumab
2
fludarabine
2
apatinib
2
Interleukin-2
2
Cyclophosphamide
2
spartalizumab
1
phosphorylethanolamine
1
olaparib
1
liposomal doxorubicin
1
ivarmacitinib
1
camrelizumab
1
anlotinib
1
Valproic Acid
1
Topotecan
1
Talc
1
Pharmaceutical Services
1
Injections
1
Hydralazine
1
Cisplatin
1
Cerebral Decortication
1
Albumin-Bound Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
olaparib
×
Other solid neoplasm
×
Clear all
NCT04375267
2026-04-14
LuPARP
Vastra Gotaland Region
Phase 1
Completed
18 enrolled